Article History
Accepted: 2 November 2023
First Online: 11 December 2023
Competing interests
: L.M. and S.L. declare no competing interests. N.C.T. has acted as an adviser to Astra Zeneca, Exact Sciences, Gilead, GlaxoSmithKline, Guardant, Inivata, Lilly, Novartis, Pfizer, Relay therapeutics, Repare therapeutics, Roche/Genentech and Zentalis, and has received research funding from Astra Zeneca, Guardant Health, Inivata, Invitae, Merck Sharpe and Dohme, Natera, Personalis, Pfizer and Roche/Genentech.